CLINICAL TRIALS PROFILE FOR TRULANCE
✉ Email this page to a colleague
All Clinical Trials for TRULANCE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01429987 ↗ | The Plecanatide Chronic Idiopathic Constipation (CIC) Study | Completed | Parexel | Phase 2/Phase 3 | 2011-10-01 | This is a randomized, double-blind, placebo controlled, 12 week repeat oral dose, dose ranging study to determine the efficacy and safety of 3 doses of plecanatide compared to placebo in patients with Chronic Idiopathic Constipation (CIC). |
NCT01429987 ↗ | The Plecanatide Chronic Idiopathic Constipation (CIC) Study | Completed | Bausch Health Americas, Inc. | Phase 2/Phase 3 | 2011-10-01 | This is a randomized, double-blind, placebo controlled, 12 week repeat oral dose, dose ranging study to determine the efficacy and safety of 3 doses of plecanatide compared to placebo in patients with Chronic Idiopathic Constipation (CIC). |
NCT01429987 ↗ | The Plecanatide Chronic Idiopathic Constipation (CIC) Study | Completed | Synergy Pharmaceuticals Inc. | Phase 2/Phase 3 | 2011-10-01 | This is a randomized, double-blind, placebo controlled, 12 week repeat oral dose, dose ranging study to determine the efficacy and safety of 3 doses of plecanatide compared to placebo in patients with Chronic Idiopathic Constipation (CIC). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TRULANCE
Condition Name
Clinical Trial Locations for TRULANCE
Trials by Country
Clinical Trial Progress for TRULANCE
Clinical Trial Phase
Clinical Trial Sponsors for TRULANCE
Sponsor Name